Starting on:
Apr 24, 2022
Ending on:
Apr 19, 2022
Moderator(s):
Venue:
Max Credits:
3 Points
Provider:
Kenya Diabetes Study Group
Claim Points
Apr 24, 2022
Ending on:
Apr 19, 2022
Moderator(s):
Max Credits:
3 Points
Provider:
Kenya Diabetes Study Group
Claim Points
Rilpivirine; an alternative First line treatment option
Starting on:
Apr 24, 2022 7:00 PM
Apr 24, 2022 7:00 PM
Ending on:
Apr 19, 2022 8:00 PM
Apr 19, 2022 8:00 PM
Venue:
Description
Rilpivirine; an alternative First line treatment option
Objectives
An alternative First line treatment option - Rilpivirine
Presenters
-
Prof.
Enoch Omonge
Lecturer Department of Clinical Medicine & Therapeutics, clinical Pharmacology Unit, University of Nairobi
-
Dr.
Josephine Ojoo
Consultant Physician
-
Dr.
Sheila Maina
Consultant Physician